Zydus Lifesciences Limited (ZYDUSLIFE) — Financial Results | 13 May 2025

· NSE 🔴 High Importance ✨ Positive
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Zydus Lifesciences Limited announced its Q4 FY25 financial results on May 20, 2025, with a net profit of ₹87.22 crores, reflecting a 32% year-on-year increase from ₹65.28 crores in the same quarter last year. The company also reported a 69.9% quarter-on-quarter rise in revenue, reaching ₹1,250 crores. The earnings call was scheduled for 4:00 PM IST on May 20, 2025, featuring a webinar with Dr. Sharvil Patel, Managing Director. Investors can access the audio recording and transcript on the company’s InvestorZone website post-event. Pre-registration is required via the provided link.

📄 View Original Announcement (PDF)

About Zydus Lifesciences Limited (ZYDUSLIFE)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,01,800.69 Cr P/E: 22.5

View full ZYDUSLIFE stock details →

📡 Get AI alerts when ZYDUSLIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ZYDUSLIFE — Free

📊 More ZYDUSLIFE filings

See all ZYDUSLIFE filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ZYDUSLIFE files new disclosures

Track ZYDUSLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ZYDUSLIFE — Free

Free account · 2 AI queries/day